Wednesday, January 4, 2012

NeurogesX picks former Poniard boss as president, CEO

Former Poniard Pharmaceuticals CEO Ron Martell replaced the retired Tony DiTonno as president and CEO of pain treatment developer NeurogesX Inc.
Martell’s base salary is $460,000, compared to a 2010 base salary of $440,214 at Poniard. He also will receive an annual target performance bonus at NeurogesX of 50 percent of the base and an option to buy 500,000 shares.

No comments:

Post a Comment